Article
Saturation resistance profiling of EGFR variants against tyrosine kinase inhibitors using prime editing
2023-12-05
Abstract excerpt
Variants of uncertain significance (VUS) hamper the clinical application of genetic information. For example, in treating lung cancer with tyrosine kinase inhibitors (TKIs), many epidermal growth factor receptor (EGFR) variants remain classified as VUS with respect to TKI sensitivity 1,2 . Such incomplete resistance profiles hinder clinicians from selecting optimal therapeutic agents 3,4 . A high-throughput appr...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e2608c93-dd71-506e-80be-3411f41bf729
- DOI
- 10.1101/2023.12.03.569825
